Composition
- Active ingredients
- VINCRISTINE SULFATE 5MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- VINCRISTINE SULFATE 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA014103-003 · Discontinued
- VINCRISTINE SULFATE 1MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA014103-001 · Discontinued
- VINCRISTINE SULFATE 5MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA014103.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Oncovin
- Active substance
- vincristine sulfate
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Lilly
- Status
- Discontinued
- FDA approval
- 10 Jul 1963
- Application
- NDA014103-002